New Drug Update: 2011
Abstract:Five new drugs that are used for medical problems often encountered in the elderly have been selected for consideration in this review. The uses and most important properties of these agents are considered, and a rating for each new drug is determined using the New Drug Comparison Rating (NDCR) system developed by the author. In the NDCR system, a rating from 1 to 5 (5 being the highest rating) is assigned for each new drug. The rating is based on a comparison of the new drug with related drugs already marketed. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating.
Keywords: A1C = Glycosylated hemoglobin; AF = Atrial fibrillation; ARB = Angiotensin II receptor blocker; Acute coronary syndrome; Anticoagulant; Antidepressant; Antidiabetic agent; Antihypertensive; Antiplatelet; Azilsartan medoxomil; Bleeding; Blood pressure; CABG = Coronary artery bypass graft; CV = Cardiovascular; DPP-4 = Dipeptidyl peptidase-4; DVT = Deep vein thrombosis; Diabetes; GIP = Glucose-dependent insulinotropic polypeptide; GLP-1 = Glucagon-like peptide-1; Linagliptin; MAOI = Monoamine oxidase inhibitor; MI = Myocardial infarction; Myocardial infarction; NDCR = New Drug Comparison Rating; NMS = Neuroleptic malignant syndrome; NSAID = Nonsteroidal anti-inflammatory drug; P-gp = P-glycoprotein; PCI = Percutaneous coronary intervention; PE = Pulmonary embolism; Replacement surgery; Rivaroxaban; SNRI = Serotonin-norepinephrine reuptake inhibitor; SSRI = Selective serotonin-reuptake inhibitor; STEMI = ST-segment elevation myocardial infarction; Selective serotonin-reuptake inhibitor; Ticagrelor; VTE = Venous thromboembolic event; Venous thromboembolic events; Vilazodone hydrochloride
Document Type: Research Article
Publication date: April 1, 2012
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites